Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,931 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiatherosclerotic Phenotype of Perivascular Adipose Tissue Surrounding the Saphenous Vein in Coronary Artery Bypass Grafting.
Mikami T, Furuhashi M, Sakai A, Numaguchi R, Harada R, Naraoka S, Kamada T, Higashiura Y, Tanaka M, Ohori S, Sakurada T, Nakamura M, Iba Y, Fukada J, Miura T, Kawaharada N. Mikami T, et al. Among authors: sakai a. J Am Heart Assoc. 2021 Apr 6;10(7):e018905. doi: 10.1161/JAHA.120.018905. Epub 2021 Mar 28. J Am Heart Assoc. 2021. PMID: 33779243 Free PMC article.
Differential regulation of hypoxanthine and xanthine by obesity in a general population.
Furuhashi M, Koyama M, Higashiura Y, Murase T, Nakamura T, Matsumoto M, Sakai A, Ohnishi H, Tanaka M, Saitoh S, Moniwa N, Shimamoto K, Miura T. Furuhashi M, et al. Among authors: sakai a. J Diabetes Investig. 2020 Jul;11(4):878-887. doi: 10.1111/jdi.13207. Epub 2020 Feb 9. J Diabetes Investig. 2020. PMID: 31916414 Free PMC article.
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy.
Furuhashi M, Sakuma I, Morimoto T, Higashiura Y, Sakai A, Matsumoto M, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Furuhashi M, et al. Among authors: sakai a. Cardiovasc Diabetol. 2020 Jun 15;19(1):89. doi: 10.1186/s12933-020-01061-0. Cardiovasc Diabetol. 2020. PMID: 32539832 Free PMC article. Clinical Trial.
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus.
Furuhashi M, Sakuma I, Morimoto T, Higashiura Y, Sakai A, Matsumoto M, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Furuhashi M, et al. Among authors: sakai a. Front Endocrinol (Lausanne). 2020 Sep 23;11:575557. doi: 10.3389/fendo.2020.575557. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33071982 Free PMC article. Clinical Trial.
Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria.
Tanaka M, Furuhashi M, Moniwa N, Maeda T, Takizawa H, Matsumoto M, Sakai A, Higashiura Y, Gocho Y, Koyama M, Ogawa Y, Miura T. Tanaka M, et al. Among authors: sakai a. BMC Nephrol. 2020 Nov 3;21(1):459. doi: 10.1186/s12882-020-02122-y. BMC Nephrol. 2020. PMID: 33143633 Free PMC article.
Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy.
Furuhashi M, Sakuma I, Morimoto T, Higashiura Y, Sakai A, Matsumoto M, Sakuma M, Shimabukuro M, Nomiyama T, Arasaki O, Node K, Ueda S. Furuhashi M, et al. Among authors: sakai a. J Atheroscler Thromb. 2022 Jan 1;29(1):24-37. doi: 10.5551/jat.58396. Epub 2020 Dec 18. J Atheroscler Thromb. 2022. PMID: 33342939 Free PMC article. Clinical Trial.
Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication.
Furuhashi M, Kataoka Y, Nishikawa R, Koyama M, Sakai A, Higashiura Y, Tanaka M, Saitoh S, Shimamoto K, Ohnishi H. Furuhashi M, et al. Among authors: sakai a. J Atheroscler Thromb. 2022 Sep 1;29(9):1275-1284. doi: 10.5551/jat.63159. Epub 2021 Sep 25. J Atheroscler Thromb. 2022. PMID: 34565765 Free PMC article.
Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.
Tanaka M, Takahashi S, Higashiura Y, Sakai A, Koyama M, Saitoh S, Shimamoto K, Ohnishi H, Furuhashi M. Tanaka M, et al. Among authors: sakai a. J Diabetes Investig. 2022 May;13(5):878-888. doi: 10.1111/jdi.13735. Epub 2022 Jan 3. J Diabetes Investig. 2022. PMID: 34889064 Free PMC article.
1,931 results